LYRINEL

This brand name is authorized in Ireland, South Africa, UK.

Active ingredients

The drug LYRINEL contains one active pharmaceutical ingredient (API):

1	Oxybutynin hydrochloride UNII L9F3D9RENQ - OXYBUTYNIN CHLORIDE
	Oxybutynin acts as a competitive antagonist of acetylcholine at post-ganglionic muscarinic receptors, resulting in relaxation of bladder smooth muscle.
	Read more about Oxybutinin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LYRINEL XL Prolonged release tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04BD04	Oxybutynin	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	381479, 45292, 45295
IE	Health Products Regulatory Authority	32300, 32309, 32329, 32383
ZA	Health Products Regulatory Authority	A39/5.4/0212, A39/5.4/0224